Therdose Pharma Private Limited

Therdose Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24239TG2003PTC042272 Incorporated 19 December 2003 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹26.66 Cr
▲ 12% YoY
Net loss · FY 2025
₹4.9 Cr
Net margin -18.4%
EBITDA · FY 2025
-₹1.89 Cr
EBITDA margin -7.1%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9.99 Cr
Issued & subscribed
Open charges
₹11.58 Cr
Satisfied ₹24.13 Cr
Company age
23 yrs
Est. 2003
Employees · EPFO
150
Provident fund records

About Therdose Pharma Private Limited

Data last updated:

Therdose Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Vance And Health Pharmaceuticals Private Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 19 December 2003 and has been in existence for over 23 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2003PTC042272. Its GSTIN is 36AAACO6469N1ZT (Telangana). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.99 Cr. It was formerly known as Oshadha Therapeutics Private Limited. It is led by directors including Ratna Sekhar Rao Imadabathuni (Managing Director) and Mahindra Dev Imadabathuni (Whole-Time Director).

Its last annual general meeting (AGM) was held on 29 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹26.66 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net loss of ₹4.9 Cr (net margin -18.4%) and EBITDA of -₹1.89 Cr (EBITDA margin -7.1%). Revenue has grown at a compounded annual rate (CAGR) of 4% over five years.

The company has about 150 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: TherDose. As per MCA filings, the company has open charges of ₹11.58 Cr and satisfied charges of ₹24.13 Cr on record. Court records list 25 cases involving the company, including 9 filed by the company and 16 filed against it; 12 cases are pending. The company has 7 deals on record (4 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹36.46 Cr; the latest was in November 2021.

Therdose Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0015163). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website therdose.com.

Company details

CIN U24239TG2003PTC042272
Registration Number 042272
Incorporation Date 19 December 2003
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Parent Company Vance And Health Pharmaceuticals Private Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0015163

CIN history

Therdose Pharma has one previous CIN (Corporate Identification Number): U24239AP2003PTC042272. The current CIN is U24239TG2003PTC042272, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239TG2003PTC042272Current
U24239AP2003PTC042272Previous

Recognitions & Rankings of Therdose Pharma

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-TS-02-0015163

Contact details

Therdose Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is therdose.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Plot No.118 119 & 120 Survey No.342 Aleap Industrialestate Opp:Jntu Pragati Nagar, Kukatpally, Hyderabad, Telangana, India – 500072
  • Industry
    Pharma, Pharma Contract R&D, Drug Formulation & Development

To see the full contact details of Therdose Pharma Private Limited, buy the company report.

Comprehensive company report
Therdose Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Therdose Pharma operates one associated brand: TherDose. Each brand links to its own profile.

BrandDescriptionWebsite
Oncology-focused generic and specialty drugs are developed and manufactured.therdose.com

Business activity

The main business activity of Therdose Pharma is professional, scientific and technical. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Therdose Pharma Private Limited, buy the company report.

Financials of Therdose Pharma Private Limited

FY 2024 filings available

Therdose Pharma Private Limited reported revenue of ₹26.66 Cr (up 12% YoY) for FY 2025.

Revenue · FY 2025
₹26.66 Cr ▲ 12%
Net loss · FY 2025
₹4.9 Cr margin -18.4%
EBITDA · FY 2025
-₹1.89 Cr margin -7.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 12%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 197%
5 years · compounded
▲ 10%

Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 12% growth in the latest year. EBITDA fell 197% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹1.89 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹4.9 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-7.1%
Net Profit Margin-18.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Therdose Pharma Private Limited, buy the company report.

Board of directors of Therdose Pharma Private Limited

Therdose Pharma has 7 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Meka Kesava Sambasiva RaoDirector26 Nov 20214 Years 11 MonthsCurrent
Narayana Raju MantanaDirector15 Apr 20242 Years 7 MonthsCurrent
Arvind Reddy PanyalaDirector26 Nov 20214 Years 11 MonthsCurrent
Mahindra Dev ImadabathuniWhole-Time Director26 Nov 20214 Years 11 MonthsCurrent
Raja Vakula Devi ImadabathuniDirector03 Oct 20224 Years 1 MonthsCurrent
Ratna Sekhar Rao ImadabathuniManaging Director12 Nov 20215 Years 0 MonthsCurrent
Showing 6 of 7 current directors. View all directors

Auditor

Therdose Pharma Private Limited is audited by R B ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
R B ASSOCIATESFY 2023009112S

Shareholding

The shareholding of Therdose Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Therdose Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹11.58 Cr
Satisfied charges
₹24.13 Cr
Breakdown by lending institutions
Others₹11.58 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
08 Dec 2022100660592Others₹11.58 CrOpen
06 May 2022100577114Axis Bank Limited₹25.68 LakhSatisfied
31 Jul 2018100266341Others₹58.75 LakhSatisfied
31 Jul 201510585321Reliance Capital Ltd₹74 LakhSatisfied
21 Mar 201210354617Others₹12.65 CrSatisfied

To see the full charge records of Therdose Pharma Private Limited, buy the company report.

Total charge records: 7 View all charges

Deals & funding

Therdose Pharma Private Limited has 7 deals on record (4 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹36.46 Cr; the latest was in November 2021.

Total deals
7
Secondary share transfers
4
Funding rounds
2
Rights issue
1
Disclosed funding
₹36.46 Cr

Deals on record (5 of 7)

WhenDealAmountParties
Nov 2021Funding round₹9.99 CrInvestors: Vance and Health Pharmaceuticals Private Limited , an individual
Sep 2016Funding round₹26.47 CrInvestors: Hitha Palepu Irrevocable Stock Trust of 2010, Robert Pragada Irrevocable Stock Trust of 2010
Mar 2015Secondary share transferUndisclosedBuyer: an individual
Seller: Scidose LLC
Sep 2014Rights issue₹19.1 LakhInvestors: 2 individuals
Nov 2008Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

To see the full deal history of Therdose Pharma Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Therdose Pharma Private Limited was last rated by Icra on 16 Jun 2022.

Rating agencyRated onRating
Icra16 Jun 2022

To see the full credit ratings and regulatory alerts of Therdose Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Therdose Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Therdose Pharma Private Limited has a workforce of 150 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
150
Active EPFO establishments
1
Employee growth
-8%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27150
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Therdose Pharma Private Limited, buy the company report.

GST

Therdose Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
36AAACO6469N1ZTTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Therdose Pharma Private Limited, buy the company report.

Recent activity

Therdose Pharma Private Limited has 23 board changes on record since 2008: 8 appointments and 15 cessations. The latest: Narayana Raju Mantana ceased to be Additional Director on 28 Sep 2024.

AGM
Therdose Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records.
Ceased
Narayana Raju Mantana ceased to be Additional Director.
Appointed
Narayana Raju Mantana was appointed as Director.
Filing
Therdose Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Others of Rs. 11.58 Cr registered on 08 Dec 2022 with Charge ID 100660592 was modified on 19 Dec 2023.
Ceased
Raja Vakula Devi Imadabathuni ceased to be Additional Director.
Charges
A charge registered on 06 May 2022 via Charge ID 100577114 with Axis Bank Limited was fully satisfied on 10 May 2023.
Charges
A charge with Others amounted to Rs. 11.58 Cr with Charge ID 100660592 was registered on 08 Dec 2022.
Appointed
Raja Vakula Devi Imadabathuni was appointed as Director.
Charges
A charge registered on 31 May 2010 via Charge ID 10229759 with Others was fully satisfied on 15 Jun 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.26 Cr with Charge ID 100577114 was registered on 06 May 2022.
Charges
A charge registered on 31 Jul 2018 via Charge ID 100266341 with Others was fully satisfied on 18 Apr 2022.

31 earlier events are in the company report.

Frequently asked questions

Therdose Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 19 December 2003 (23+ years old) and is registered under CIN U24239TG2003PTC042272.

Therdose Pharma has 7 current directors:

The latest financial statements of Therdose Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 29 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Therdose Pharma is 36AAACO6469N1ZT, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of Therdose Pharma is U24239TG2003PTC042272. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Therdose Pharma has 25 court cases on record: 9 filed by the company and 16 filed against it. 12 are pending. Most are in the district courts.

Therdose Pharma was incorporated on 19 December 2003, making it 23+ years old. It is registered with the Registrar of Companies, Hyderabad.

Therdose Pharma has 7 deals on record (4 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹36.46 Cr; the latest was in November 2021.

Narayana Raju Mantana ceased to be Additional Director on 28 Sep 2024. Narayana Raju Mantana was appointed as Director on 15 Apr 2024. Raja Vakula Devi Imadabathuni ceased to be Additional Director on 28 Sep 2023. Therdose Pharma has 23 board changes on record in total.

Yes, Therdose Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0015163).